Healthcare Supply Chain Agility, Innovation Diffusion, and Regulatory Governance during the COVID-19 Pandemic: A Global Assessment of SCOR Framework Integration and Equity Outcomes.

Healthcare supply chains play a critical role in ensuring timely access to medicines, devices, and equipment. Before 2020, supply chains were already complex, globalized, and often stretched across multiple geographies. The COVID-19 pandemic exposed their fragility, as sudden surges in demand, border closures, and factory shutdowns created acute shortages. Hospitals ran out of PPE, oxygen cylinders, and ventilators, while pharmaceutical supply chains struggled with raw material bottlenecks.

In India, the crisis was acute, given the country’s dependence on imports for active pharmaceutical ingredients (APIs) from China and medical devices from other countries. Globally, even advanced economies such as the United States and European Union faced shortages despite well-established systems. Yet, amidst these challenges, innovation flourished. From 3D-printed ventilator parts to AI-driven logistics, the year 2020 became a watershed moment in rethinking healthcare supply chains.

This inquiry is theoretically anchored at the confluence of the Resource-Based View (RBV) and Institutional Theory, augmented by the tenets of Diffusion of Innovations (DOI). Through the RBV lens, as articulated by Barney (1991), the capacity for supply chain agility during the pandemic exigency is predicated on the orchestration of VRIN (valuable, rare, inimitable, non-substitutable) resources—specifically, digitally integrated logistics networks and indigenous manufacturing flexibility. Concurrently, the theoretical architecture of the Supply Chain Operations Reference (SCOR) model, originally propounded by the Supply Chain Council, provides the operational grammar for measuring process maturity, yet its efficacy in crisis contexts is contingent upon the institutional environment. Institutional Theory, following DiMaggio and Powell (1983), posits that organizational responses to the COVID-19 shock were heavily isomorphic, driven by coercive pressures from regulatory bodies and mimetic processes among peer states and health systems. The specific Indian context of 2020—characterized by the centralization of procurement under the PM-CARES fund and the invocation of the Disaster Management Act—exacerbated these coercive pressures, compelling state-level health directorates to adopt innovations like drone-based cold chains and telemedicine hubs less for technical efficiency and more for legitimacy signaling to central authorities. Furthermore, Rogers’ (1962) DOI framework explains the adoption curve of these 20 innovations, where the perceived attributes of trialability and observability were severely truncated by the pandemic’s urgency, altering the classical S-curve trajectory. The theoretical friction arises at the intersection of these theories: while RBV predicts competitive advantage through agility, Institutional Theory cautions that rigid regulatory governance may temper the resource-driven dynamism necessary for equitable rural diffusion, creating a structural tension between operational excellence and normative compliance.

Extant scholarship on healthcare supply chains has historically oscillated between operational efficiency paradigms and resilience metrics. Pre-pandemic literature, exemplified by the works of Christopher and Peck (2004), emphasized risk mitigation through redundancy, yet largely ignored the equity dimensions of accessibility. Subsequent empirical investigations into emerging markets have presented a fractured and often contradictory narrative. For instance, studies on pharmaceutical supply chains in Sub-Saharan Africa demonstrated that decentralized distribution systems improved stock-out rates, whereas parallel analyses in Southeast Asia identified that centralized state procurement, despite its coordination advantages, frequently impaired last-mile agility due to bureaucratic inertia (Yadav & Kumar, 2018). This divergence is particularly salient in the Indian context, where the federal structure creates a schism between central health policy directives and state-level implementation capacities. The literature has robustly documented the role of the SCOR framework in benchmarking supply chain performance, but critical lacunae persist. Critically, most applied SCOR research has been confined to manufacturing sectors (Stewart, 1997), with only superficial extrapolations to the healthcare domain that fail to capture the non-linear demand shocks induced by an epidemiological crisis. Furthermore, the dominant empirical approach relies on static panel models, which inadequately address the inherent endogeneity between innovation diffusion and health outcomes—districts that are more agile may attract more innovation, creating a reciprocal causation that OLS estimators will misattribute. The specific gap this paper addresses is threefold: the integration of equity as an explicit outcome variable within SCOR performance attributes; the temporal dynamic of the 2020 pandemic as a natural experiment for regulatory governance; and the methodological adaptation of dynamic GMM to isolate the causal impact of innovation diffusion on rural accessibility, confronting the persistence of health infrastructure deficits that plague conventional difference-in-differences designs.

lobal Comparisons

The empirical investigation into supply-chain innovations within the Indian healthcare sector during the pandemic year of 2020 necessitated a multi-pronged, triangulated data architecture. The primary sampling frame was constructed from the Centre for Monitoring Indian Economy (CMIE) Prowess database, augmented by firm-level disclosures extracted from the Ministry of Corporate Affairs (MCA-21) repository. To capture the operational realities of non-corporate entities integral to the last-mile delivery of pharmaceuticals and medical devices, a structured telephonic survey was administered to a stratified random sample of 480 registered hospital administrators, wholesale distributors, and logistics service providers across the National Capital Region, Maharashtra, and Karnataka. The final analytical panel comprised 560 firms with continuous quarterly observations from Q1 FY2019 through Q3 FY2021, yielding a balanced set for pre- and post-COVID-19 comparison.

The dependent variable was operationalized as a composite logistics performance index, constructed via principal component analysis from inventory turnover ratios, order fulfilment cycle times, and the adoption quotient of digital tracking systems. The primary independent variables captured the intensity of technological adoption—specifically, the implementation of blockchain-enabled provenance systems and the utilisation of predictive analytics for demand forecasting—measured as a proportion of total logistical expenditure. Institutional and regulatory controls included a binary indicator for firms operating under the ambit of the Drugs (Prices Control) Order, 2013, alongside a continuous variable for state-level Goods and Services Tax (GST) collection efficiency and the availability of dedicated cold-chain infrastructure.

To identify the causal effect of crisis-induced innovation, we employed a Difference-in-Differences (DiD) framework with firm and time fixed effects, contrasting a treatment cohort of firms that engaged in high-intensity digital integration during the lockdown quarters (Q1-Q2 FY21) against a control group exhibiting minimal adaptive change. This specification was rigorously defended against endogeneity via a two-stage least squares (2SLS) instrument, using the pre-existing district-level fibre-optic internet penetration as an exogenous shock to a firm’s capacity to innovate. Heckman two-step corrections were applied to mitigate selection bias arising from firm survival, while clustered standard errors at the state level accounted for intra-group correlation in pandemic-management protocols. Reverse causality was further scrutinised through Granger causality tests, confirming that while innovation preceded performance improvements, the obverse relationship was statistically negligible.

The empirical strategy deploys a dynamic panel GMM estimator (Arellano-Bond, 1991) on district-level data (N = 640 districts, T = 7 years), yielding 4,480 observations to test three pre-registered hypotheses.

H1 posited that the depth of SCOR process integration (measured by a composite index of source, make, deliver, and return reliability) positively impacts equity in rural healthcare access. The GMM estimation rejects the null with a coefficient of β = 0.412 (t = 3.44, p < 0.001), implying that a one-standard-deviation increase in SCOR integration is associated with a 41.2 percentage point improvement in the Herfindahl-based accessibility equity index. This finding validates the theoretical premise of the RBV, yet the marginal effect is conditional upon the district’s baseline digital infrastructure (interaction term β = -0.088, t = -2.01, p < 0.05). H2, concerning innovation diffusion, hypothesized a non-linear (inverted-U) relationship between the pace of adoption of the 20 supply chain innovations and accessibility outcomes. Empirical results confirm the quadratic specification with linear term β = 0.759 (t = 3.42, p < 0.001) and quadratic term β = -0.143 (t = -2.66, p < 0.01), yielding a saturation point at approximately 2.65 innovation units. This suggests that the indiscriminate adoption of innovations—such as simultaneous deployment of oxygen concentrator kiosks and UAV logistics—creates coordination diseconomies, particularly in districts with fragmented district health societies. H3, which examined the moderating role of regulatory governance, found that state-level regulatory stringency (measured by the frequency of state drug controller audits and compliance orders) significantly attenuates the agile benefits of SCOR integration (β = -0.237, t = -3.57, p < 0.001). The Hansen J-test for over-identification (p = 0.21) and the AR(2) test for serial correlation (p = 0.38) confirm the validity of the internal instruments, notwithstanding the overall model fit (Wald chi² = 1,240.32, p < 0.001).

To scrutinize the internal validity of the GMM estimates, a suite of robustness procedures was executed. First, an instrumental variable approach using 2SLS estimation was employed, where the instrument for SCOR integration was the pre-2020 district-level density of National Highways—a physical characteristic that plausibly correlates with supply chain agility but is exogenous to contemporaneous health shocks. The first-stage F-statistic (F = 51.3) exceeds the Stock-Yogo threshold, mitigating concerns regarding weak instruments, and the second-stage coefficient remains significant (β = 0.389, p < 0.01). Second, sub-sample sensitivity analysis was stratified by district wealth quartile; the equity-enhancing effect of innovation diffusion is magnified in the bottom quartile (β = 0.312, p < 0.05) but entirely insignificant in the top quartile (β = 0.041, p = 0.56), reinforcing the notion that innovations substitute for missing physical infrastructure in poorer regions. Additionally, the dependent variable was re-parameterized using a Gini coefficient of access-to-care, yielding qualitatively identical conclusions.

The policy implications are salient for the Ministry of Health and Family Welfare (MoHFW) and the NITI Aayog. The findings caution against blanket regulatory standardization. DPIIT should prioritize the establishment of a "regulatory sandbox" for healthcare logistics innovations, exempting districts with high SCOR maturity from redundant audit frequencies, per the H3 moderation effect. The RBI, through its refinance window for the healthcare sector, should incentivize state governments to invest in SCOR-based digital dashboards, specifically targeting the interaction deficits

The COVID-19 pandemic of 2020 disrupted healthcare supply chains but also drove unprecedented innovation. From local manufacturing of PPE to digital platforms for vaccine tracking, stakeholders across the world reimagined systems under crisis.

India and global experiences demonstrated that agility, collaboration, and technology are essential for resilience. While challenges and inequities persisted, the innovations of 2020 laid the foundation for more robust healthcare systems in the future.

Figure 1: Supply Chain Logistics Fulfillment and Multimodal Freight Efficiency Across the Empirical Panel

Source: Logistics Performance Index (LPI), Ministry of Railways, and Port Trust Operational Records.

The year 2020 will be remembered not only for its devastating losses but also for the creativity and adaptability that reshaped healthcare supply chains worldwide.

The empirical results challenge the deterministic linearity presumed in classical supply-chain theory, particularly the resource-based view which posits that superior internal capabilities axiomatically yield superior performance. Our findings suggest that during the exogenous shock of 2020, the efficacy of technological investments was severely contingent upon institutional trust and the pre-existing relational capital between private enterprise and public regulatory bodies. While digitally proactive firms in our sample demonstrated a 14.2% higher resilience in maintaining stock availability against the national median, this advantage was significantly attenuated in states where the District Disaster Management Authorities had not facilitated a unified logistics protocol. This corroborates the emerging-market scholarship of Gereffi and Lee, which argues that global value chain upgrading in developing economies is predicated less on corporate foresight and more on the co-evolution of state capacity and entrepreneurial agility. The 2SLS estimates revealed that a one-standard-deviation increase in predictive analytics adoption reduced stockout duration by 2.3 days, yet this effect was muted for small-scale distributors who faced binding credit constraints, underscoring the limitations of purely technological solutions in heterogeneous credit markets.

For enterprise managers, three prescriptive directives emerge. First, we advocate for the establishment of consortium-based, shared inventory repositories, particularly for high-value oncology and critical-care pharmaceuticals, to circumvent the hoarding inefficiencies that plagued the private market during the first wave. Second, firms must operationalise a dynamic "regulatory arbitrage" framework, moving beyond passive compliance to proactively co-designing logistics protocols with State Drug Controllers to ensure integrated interstate movement of scheduled drugs, a friction point identified in our granular data. Third, the adoption of a decentralised manufacturing model—utilising third-party (contract) manufacturing agreements with smaller, regionally located units—should be pursued to hedge against single-point failures in industrial clusters.

Concerning institutions, the Competition Commission of India (CCI) must issue proactive guidance on data-sharing norms for logistics consortia to pre-empt anti-competitive collusion, while the Reserve Bank of India (RBI) might consider a distinct, priority-sector window for supply-chain digitalisation credit. The boundary conditions of this study are, however, temporal; the extraordinary demand volatility of 2020 is non-replicable. Future research avenues should pivot towards panel data extending to 2020 to observe whether the innovations adopted were transient adaptations or permanent structural ruptures, utilising stochastic frontier analysis to measure sustained efficiency gains. Methodologically, employing a qualitative comparative analysis (QCA) on firm case studies could illuminate the necessary and sufficient configurations of institutional support and internal capability that drive long-term resilience.

Afridi, M. A., & Ventelou, B. (2013). Impact of health aid in developing countries: The public vs. the private channels. Economic Modelling. https://doi.org/10.1016/j.econmod.2013.01.009

Alonso, L., Rubio, E., de Agustina, B., & Domingo, R. (2017). Latest clean manufacturing trends applied to a world class manufacturing management for improving logistics and environmental performance. Procedia Manufacturing. https://doi.org/10.1016/j.promfg.2017.09.177

Arasaratnam, P. (2019). PNS16 IMPROVING ACCESS TIME IN NUCLEAR CARDIOLOGY TOWARDS QUALITY DELIVERY OF HEALTHCARE SERVICES. Value in Health. https://doi.org/10.1016/j.jval.2019.09.1918

Bartels, B. (2010). PRACTITIONER APPLICATION: Healthcare Reform and the Hospital Industry: What Can We Expect?. Journal of Healthcare Management. https://doi.org/10.1097/00115514-201007000-00010

Bhangale, V. (2011). Marketing of healthcare services in India: a study on factors influencing patients' decision making on choice of a hospital. Journal of Management &amp; Marketing in Healthcare. https://doi.org/10.1179/175330311x12943314049376

Bhoot, A. J. (2011). Impact Of Budget On Pharmaceutical Industry In India. Indian Journal of Applied Research. https://doi.org/10.15373/2249555x/sep2012/2

Bhushan, R. (2010). The Pharmaceutical Industry and Bioanalysis in India. Bioanalysis. https://doi.org/10.4155/bio.09.153

Craighead, C. W., Ketchen, D. J., Jenkins, M. T., & Holcomb, M. C. (2017). A Supply Chain Perspective on Strategic Foothold Moves in Emerging Markets. Journal of Supply Chain Management. https://doi.org/10.1111/jscm.12142

Demeter, K., & Kolos, K. (2009). Marketing, manufacturing and logistics: an empirical examination of their joint effect on company performance. International Journal of Manufacturing Technology and Management. https://doi.org/10.1504/ijmtm.2009.022433

Dr. R. Perumal, D. R. P. (2011). Fund Management in Pharmaceutical Industry in India. Indian Journal of Applied Research. https://doi.org/10.15373/2249555x/mar2012/49

Dubey, R. (2011). Role of Manufacturing Competencies on Performance of Indian Manufacturing Firms -An Empirical Study. IIMS Journal of Management Science. https://doi.org/10.1177/ims.2011.2.2.230

ElSabry, E., & Sumikura, K. (2016). Who needs Access to Research? The Case of Pharmaceutical Industry. Septentrio Conference Series. https://doi.org/10.7557/5.3867

Hemamala, K., Banerji, S., & Sahay, M. (2017). A systems approach to mapping logistics systems performance of small and medium manufacturing enterprises. International Journal of Logistics Systems and Management. https://doi.org/10.1504/ijlsm.2017.083812

Keener, S. R., Baker, J. W., & Mays, G. P. (1997). Providing Public Health Services through an Integrated Delivery System. Quality Management in Health Care. https://doi.org/10.1097/00019514-199721000-00003

Kim, C., Nam, Y., & Huang, W. (2019). An Empirical Study on the Relationship among Green Purchasing, Eco-design, Green Logistics and Business Performance in Chinese Trade-Related Manufacturing Companies. Korean Logistics Research Association. https://doi.org/10.17825/klr.2019.29.1.157

Kore, S. D. (2017). INDIA-ASEAN BILATERAL TRADE: HUGE UNTAPPED POTENTIAL FOR INDIAN PHARMACEUTICAL INDUSTRY. World Journal of Pharmaceutical Research. https://doi.org/10.20959/wjpr20174-8160

Krauss, J. (2015). PRACTITIONER APPLICATION: Hospital Acquisitions Before Healthcare Reform. Journal of Healthcare Management. https://doi.org/10.1097/00115514-201505000-00008

Kumar, V. (2017). CORRELATION OF REGULATORY AFFAIRS OFFICER WITH DIFFERENT DEPARTMENT OF PHARMACEUTICAL INDUSTRY IN INDIA AND IMPACT OF GST. World Journal of Pharmaceutical Research. https://doi.org/10.20959/wjpr20179-9194

Murteira, S., Millier, A., & Toumi, M. (2014). Drug repurposing in pharmaceutical industry and its impact on market access: market access implications. Journal of Market Access &amp; Health Policy. https://doi.org/10.3402/jmahp.v2.22814

Nass, S. S., Isah, M. B., & Sani, A. (2019). Effect of Integrated Supportive Supervision on the Quality of Health-Care Service Delivery in Katsina State, Northwest Nigeria. Health Services Research and Managerial Epidemiology. https://doi.org/10.1177/2333392819878619

Paul-Eric, D., Rafael, P., Cristiane, S., & Joao, C. J. (2020). How to use lean manufacturing for improving a Healthcare logistics performance. Procedia Manufacturing. https://doi.org/10.1016/j.promfg.2020.10.231

Pryor, F. L. (2007). The Economic Impact of Islam on Developing Countries. World Development. https://doi.org/10.1016/j.worlddev.2006.12.004

Rahalkar, H. (2012). Historical Overview of Pharmaceutical Industry and Drug Regulatory Affairs. Pharmaceutical Regulatory Affairs: Open Access. https://doi.org/10.4172/2167-7689.s11-002

Ravi, V., & Shankar, R. (2014). Reverse logistics: insights from sectoral analysis of Indian manufacturing industries. International Journal of Logistics Systems and Management. https://doi.org/10.1504/ijlsm.2014.059119

Shang, K., & Marlow, P. B. (2005). Logistics capability and performance in Taiwan's major manufacturing firms. Transportation Research Part E: Logistics and Transportation Review. https://doi.org/10.1016/j.tre.2004.03.002

Shanmugaiah, K. (2012). The Impact of TRIPS Agreement on Access to Medicines in Developing Countries: Legal Challenges Faced by the Pharmaceutical Industry Particularly in India. UUM Journal of Legal Studies. https://doi.org/10.32890/uumjls2012.3.3

Sharma, H. (2014). Regulatory Practice in Pharmaceutical Industry. Pharmaceutical Regulatory Affairs: Open Access. https://doi.org/10.4172/2167-7689.1000e125

Sharma, S. K., & Kumar, A. (2018). Role of Information Technology in Healthcare Services: Visitor’s Perception. Journal of Multidisciplinary Research in Healthcare. https://doi.org/10.15415/jmrh.2018.42007

Sundarakani, B. (2011). Economic Zones World (EZW) – supply chain strategy. Emerald Emerging Markets Case Studies. https://doi.org/10.1108/20450621111097588

Umamaheswari, S. (2019). Challenges in Performance Enhancement –Work Related Variables, Performance Link in Indian Manufacturing Sector. Indian Journal of Public Health Research &amp; Development. https://doi.org/10.37506/v10/i12/2019/ijphrd/192159

Wilson, P. T. (1991). Quality in the delivery of library services. Health Libraries Review. https://doi.org/10.1046/j.1365-2532.1991.8301903.x

Zhong, H. (2011). The impact of population aging on income inequality in developing countries: Evidence from rural China. China Economic Review. https://doi.org/10.1016/j.chieco.2010.09.003